Quality of life (QOL) evaluation within a randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable, advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study.
Y. Ohashi
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
M. Tanaka
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
N. Boku
Consultant or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
H. Ueno
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Lilly; Taiho Pharmaceutical
T. Okusaka
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Lilly; Taiho Pharmaceutical
Research Funding - Lilly; Taiho Pharmaceutical